CSPC PHARMA(01093),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

01093 CSPC PHARMA

Pre-opening 11-05 09:21:54

8.500

+0.140

+1.67%

High8.500	Low8.500	Vol198.00K
Open8.500	D1 Closing8.360	Amplitude0.00%
Mkt Cap97.94B	Tradable Cap97.94B	Total Shares11.52B
T/O1.68M	T/O Rate0.00%	Tradable Shares11.52B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"01093","market":"HK","secType":"STK","nameCN":"CSPC PHARMA","latestPrice":8.5,"timestamp":1793841612190,"preClose":8.36,"halted":0,"volume":198000,"delay":0,"changeRate":0.01674641148325366,"floatShares":11522000000,"shares":11522000000,"eps":0.39949733253832515,"marketStatus":"Pre-opening","change":0.14,"latestTime":"11-05 09:21:54","open":8.5,"high":8.5,"low":8.5,"amount":1683000,"amplitude":0,"askPrice":8.5,"askSize":8000,"bidPrice":8.48,"bidSize":4000,"shortable":3,"etf":0,"ttmEps":0.7647975523293218,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1793842200000},"marketStatusCode":1,"adr":0,"listingDate":772128000000,"exchange":"SEHK","adjPreClose":8.36,"dividendRate":0.038859,"openAndCloseTimeList":[[1793842200000,1793851200000],[1793854800000,1793865600000]],"volumeRatio":0,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"CSP.HK","impliedVol":0.4042,"impliedVolPercentile":0.065},"requestUrl":"/m/hq/s/01093/tweets","defaultTab":"tweets","newsList":[{"id":"2680033353","title":"CSPC Pharmaceutical Group Stock Climbs 6.5% in Hong Kong, Outperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2680033353","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680033353?lang=en_us&edition=fundamental","pubTime":"2026-11-04 16:30","pubTimestamp":1793781000,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of CSPC Pharmaceutical Group Ltd. rallied 6.5% to 8.36 Hong Kong dollars on what proved to be an all-around positive trading session for the Hong Kong stock market, with the Hang Seng Index rising 1.7% to 23919.50.CSPC Pharmaceutical Group Ltd. closed 24% below its 52-week high of HK$10.96, which the company achieved Jan. 30.The stock outperformed some of its competitors, as Sino Biopharmaceutical Ltd. rose 5.4%, SSY Group Ltd. rose 1.6%, and United Laboratories International Holdings Ltd. rose 4.0%.Trading volume totaled 196.2 million shares, compared to the 50-day average of 84.3 million shares.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B543WZ88.USD","HK0000165453.HKD","LU1993786604.SGD","LU1226287792.SGD","LU1960683339.HKD","LU1951186391.HKD","LU1226287875.USD","LU1152091168.USD","KURE","LU1226287529.USD","IE00BZ08YT58.USD","LU1807302812.USD","LU1152091754.HKD","LU1008478684.HKD","LU0072913022.USD","LU1226288253.USD","BK1515","LU0326950275.SGD","IE00BZ08YS42.EUR","LU0315179316.USD","IE00B031HY20.USD","BK1191","LU0140636845.USD","LU1328277881.USD","SG9999004220.SGD","IE00B5MMRT66.SGD","IE00BZ08YR35.GBP","LU0501845795.SGD","LU0880133367.SGD","LU1813983027.USD","BK1521","LU0067412154.USD","LU1226288170.HKD","01093","IE0008369823.USD","IE0008368742.USD","LU0314109678.HKD","LU2039709279.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146929933","title":"Movement Alert｜CSPC PHARMA Intraday Rise 3.44% in Regular Trading, backed by new China trial starts for hypertension and tumor drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=1146929933","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146929933?lang=en_us&edition=fundamental","pubTime":"2026-11-04 13:32","pubTimestamp":1793770370,"startTime":"0","endTime":"0","summary":"On November 4, CSPC PHARMA saw an Intraday Rise of 3.44% in Regular Trading, with the stock trading at HK$8.125 and turnover reaching HK$561 million.The clearest fresh catalyst was the companys...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"CSPC PHARMA Jumps on New China Trials for Hypertension and Tumor Drugs","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680725740","title":"CSPC Pharma Begins Tumor Drug Trial in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2680725740","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680725740?lang=en_us&edition=fundamental","pubTime":"2026-11-03 20:15","pubTimestamp":1793708123,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group (HKG:1093) officially began a phase I/II clinical trial of SYS6088 injection at the first center in China.The drug is being tested for the treatment of advanced solid tumors, a Tuesday bourse filing showed.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1226288170.HKD","IE00BZ08YT58.USD","LU1813983027.USD","IE0008369823.USD","IE00B543WZ88.USD","LU1152091754.HKD","HK0000165453.HKD","LU1328277881.USD","LU1226287792.SGD","LU1226288253.USD","SG9999004220.SGD","LU1951186391.HKD","LU1152091168.USD","BK1521","LU2039709279.SGD","IE00B5MMRT66.SGD","LU1226287529.USD","KURE","BK1515","LU1960683339.HKD","LU0501845795.SGD","LU0314109678.HKD","BK1191","LU0880133367.SGD","01093","LU0067412154.USD","IE00B031HY20.USD","IE0008368742.USD","IE00BZ08YR35.GBP","LU1807302812.USD","IE00BZ08YS42.EUR","LU0072913022.USD","LU1226287875.USD","LU0315179316.USD","LU0140636845.USD","LU1993786604.SGD","LU1008478684.HKD","LU0326950275.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192034798","title":"CSPC Pharma Begins First-in-Human Phase I/II Trial of Trispecific Antibody SYS6088 for Advanced Solid Tumors in China","url":"https://stock-news.laohu8.com/highlight/detail?id=1192034798","media":"Bulletin Express","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192034798?lang=en_us&edition=fundamental","pubTime":"2026-11-03 18:40","pubTimestamp":1793702455,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group Limited (CSPC Pharma) has officially started a combined Phase I/II clinical trial of SYS6088 injection, a recombinant humanised trispecific antibody designed for patients...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196948865","title":"CSPC Pharma's SYS6088 Injection Begins Phase I/II Clinical Trial in China for Advanced Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=1196948865","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196948865?lang=en_us&edition=fundamental","pubTime":"2026-11-03 18:34","pubTimestamp":1793702054,"startTime":"0","endTime":"0","summary":"CSPC Pharma (01093) has announced that the Phase I/II clinical trial (SYS6088-001) of SYS6088 Injection, developed by the company for the treatment of advanced solid tumors, has officially commenced...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0067412154.USD","BK1515","IE00B543WZ88.USD","IE0008368742.USD","LU1960683339.HKD","SG9999004220.SGD","KURE","LU0880133367.SGD","LU1807302812.USD","LU0314109678.HKD","LU1226287792.SGD","IBBJ","IE00BZ08YT58.USD","BK1191","LU1226287875.USD","LU1226288170.HKD","BK1521","LU1008478684.HKD","LU1226288253.USD","MDTX","LU1993786604.SGD","HK0000165453.HKD","LU2039709279.SGD","IE00BZ08YR35.GBP","BMED","LU1152091754.HKD","LU1813983027.USD","LU1226287529.USD","IE0008369823.USD","LU0140636845.USD","IE00B5MMRT66.SGD","LU0326950275.SGD","LU1152091168.USD","IE00B031HY20.USD","IBBQ","LU0501845795.SGD","LU1328277881.USD","IE00BZ08YS42.EUR","LU0072913022.USD","LU1951186391.HKD","01093","PSYK","LU0315179316.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680744490","title":"CSPC Pharmaceutical Starts Phase II Trial of Syh2072 for Hypertension in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2680744490","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680744490?lang=en_us&edition=fundamental","pubTime":"2026-11-03 18:26","pubTimestamp":1793701601,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Starts Phase II Trial of SYH2072 for Hypertension in ChinaCSPC Pharmaceutical Group announced on Nov. 3, 2026, the initiation of its Phase II SYH2072 hypertension trial at China's ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261103:nNDL5r7yKT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0072913022.USD","IE00B5MMRT66.SGD","LU0880133367.SGD","LU1813983027.USD","LU2039709279.SGD","LU1226287792.SGD","LU0314109678.HKD","KURE","LU1951186391.HKD","LU1993786604.SGD","IE00BZ08YS42.EUR","LU1807302812.USD","LU0067412154.USD","BK1515","IE00B543WZ88.USD","SG9999004220.SGD","IE00BZ08YR35.GBP","LU1008478684.HKD","IE0008369823.USD","IE00B031HY20.USD","IE00BZ08YT58.USD","LU0326950275.SGD","HK0000165453.HKD","LU1226287875.USD","LU1152091168.USD","IE0008368742.USD","LU1226288170.HKD","BK1191","LU1152091754.HKD","LU1226288253.USD","LU0315179316.USD","LU1960683339.HKD","BK1521","LU0140636845.USD","LU1328277881.USD","01093","LU1226287529.USD","LU0501845795.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680648597","title":"Cspc Pharmaceutical Initiates Phase I/II Trial of Sys6052 Herpes Zoster Vaccine in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2680648597","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680648597?lang=en_us&edition=fundamental","pubTime":"2026-11-03 01:17","pubTimestamp":1793639864,"startTime":"0","endTime":"0","summary":"BRIEF-Cspc Pharmaceutical Initiates Phase I/II Trial Of SYS6052 Herpes Zoster Vaccine In ChinaNov 2 (Reuters)-CSPC PHARMACEUTICAL GROUP LIMITED1093.HK:CO INITIATES PHASE I/II TRIAL OF SYS6052 HERPES ZOSTER VACCINE IN CHINAFurther company coverage:1093.HK","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261102:nFWN46J11M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1008478684.HKD","BK1515","LU1226288170.HKD","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","LU1152091754.HKD","LU1226288253.USD","IE0008369823.USD","IE00B031HY20.USD","LU0140636845.USD","SG9999004220.SGD","IE00BZ08YT58.USD","BK1521","LU1328277881.USD","BK1191","LU0067412154.USD","LU1960683339.HKD","LU0326950275.SGD","LU1226287529.USD","IE0008368742.USD","IE00B5MMRT66.SGD","LU0072913022.USD","01093","LU1993786604.SGD","LU1226287875.USD","LU1152091168.USD","HK0000165453.HKD","IE00B543WZ88.USD","LU1807302812.USD","LU0314109678.HKD","LU1226287792.SGD","LU0315179316.USD","LU0501845795.SGD","KURE","LU2039709279.SGD","LU1813983027.USD","LU1951186391.HKD","LU0880133367.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680515597","title":"CSPC Pharma Begins Two Vaccine Trials in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2680515597","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680515597?lang=en_us&edition=fundamental","pubTime":"2026-11-02 19:53","pubTimestamp":1793620385,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group (HKG:1093) officially initiated two clinical trials in China, two Monday bourse filings showed.The pharma company is testing SYS6052, a recombinant herpes zoster virus vaccine, and SYS6057, a recombinant respiratory syncytial virus vaccine.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1813983027.USD","HK0000165453.HKD","LU0314109678.HKD","IE00B031HY20.USD","LU1226287529.USD","LU1951186391.HKD","LU1328277881.USD","LU1226287792.SGD","LU1226287875.USD","IE00BZ08YS42.EUR","LU1807302812.USD","SG9999004220.SGD","LU1152091754.HKD","KURE","LU1008478684.HKD","LU0067412154.USD","LU0501845795.SGD","LU1960683339.HKD","LU0315179316.USD","BK1191","BK1515","LU2039709279.SGD","LU0072913022.USD","LU1226288253.USD","LU0140636845.USD","LU1226288170.HKD","BK1521","IE00B5MMRT66.SGD","LU1152091168.USD","01093","LU1993786604.SGD","LU0326950275.SGD","LU0880133367.SGD","IE00BZ08YR35.GBP","IE0008369823.USD","IE0008368742.USD","IE00BZ08YT58.USD","IE00B543WZ88.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680575902","title":"CSPC Pharma Gets Positive Results from Triple Combination Regimen Trial for Diabetes Mellitus","url":"https://stock-news.laohu8.com/highlight/detail?id=2680575902","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680575902?lang=en_us&edition=fundamental","pubTime":"2026-11-02 19:49","pubTimestamp":1793620149,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group's  obtained positive topline results in a phase III trial of the triple combination therapy of prusogliptin, dapagliflozin, and metformin in patients with type 2 diabetes mellitus.The results showed significant superiority in reduction in HbA1c from baseline in patients given the drug combination versus those receiving dapagliflozin or prusogliptin in combination with metformin.The triple combination therapy regimen also demonstrated a favorable safety profile.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1226288170.HKD","IE00BZ08YT58.USD","LU1813983027.USD","IE0008369823.USD","IE00B543WZ88.USD","LU1152091754.HKD","HK0000165453.HKD","LU1328277881.USD","LU1226287792.SGD","LU1226288253.USD","SG9999004220.SGD","LU1951186391.HKD","LU1152091168.USD","BK1521","LU2039709279.SGD","IE00B5MMRT66.SGD","LU1226287529.USD","KURE","BK1515","LU1960683339.HKD","LU0501845795.SGD","LU0314109678.HKD","BK1191","LU0880133367.SGD","01093","LU0067412154.USD","IE00B031HY20.USD","IE0008368742.USD","IE00BZ08YR35.GBP","LU1807302812.USD","IE00BZ08YS42.EUR","LU0072913022.USD","LU1226287875.USD","LU0315179316.USD","LU0140636845.USD","LU1993786604.SGD","LU1008478684.HKD","LU0326950275.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160837185","title":"CSPC Pharmaceutical Reports Successful Phase III Results for Prusogliptin-Based Triple Therapy in Type 2 Diabetes","url":"https://stock-news.laohu8.com/highlight/detail?id=1160837185","media":"Bulletin Express","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160837185?lang=en_us&edition=fundamental","pubTime":"2026-11-02 19:03","pubTimestamp":1793617414,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group Limited announced positive topline data from a multicentre, randomised, double-blind, parallel-controlled Phase III trial assessing a triple regimen of Prusogliptin Tablets...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142759526","title":"CSPC PHARMA Initiates Phase I Clinical Trial for Recombinant RSV Vaccine SYS6057 in China","url":"https://stock-news.laohu8.com/highlight/detail?id=1142759526","media":"Bulletin Express","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142759526?lang=en_us&edition=fundamental","pubTime":"2026-11-02 19:02","pubTimestamp":1793617365,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group Limited (CSPC PHARMA) has commenced a Phase I clinical study of SYS6057, its in-house developed recombinant respiratory syncytial virus (RSV) vaccine produced in Chinese...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107983149","title":"CSPC Pharma Maintains Stable Share Capital in October 2026, Confirms Public Float Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=1107983149","media":"Bulletin Express","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107983149?lang=en_us&edition=fundamental","pubTime":"2026-11-02 19:01","pubTimestamp":1793617314,"startTime":"0","endTime":"0","summary":"For the month ended 31 October 2026, CSPC Pharmaceutical Group Limited reported no movement in its issued share capital. The number of ordinary shares in issue remained at 11.52 billion, with zero...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101293572","title":"CSPC Pharma's Prucalopride Combined with Dapagliflozin and Metformin HCl Extended-Release Tablets Achieves Positive Topline Results in Phase III Trial for Type 2 Diabetes","url":"https://stock-news.laohu8.com/highlight/detail?id=1101293572","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101293572?lang=en_us&edition=fundamental","pubTime":"2026-11-02 18:54","pubTimestamp":1793616857,"startTime":"0","endTime":"0","summary":"CSPC Pharma (01093) has announced that the Phase III clinical trial of its developed Prucalopride Tablets in combination with Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets for...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B031HY20.USD","LU2039709279.SGD","LU1152091754.HKD","IE00BZ08YS42.EUR","MDTX","KURE","HK0000165453.HKD","IE00BZ08YT58.USD","IE00BZ08YR35.GBP","BMED","LU1008478684.HKD","BK1191","IE00B543WZ88.USD","LU1226287792.SGD","LU1960683339.HKD","IBBQ","PSYK","LU1807302812.USD","LU0880133367.SGD","LU0314109678.HKD","LU1328277881.USD","LU1226287529.USD","LU0140636845.USD","LU0315179316.USD","LU1993786604.SGD","IE0008368742.USD","LU0072913022.USD","LU1226288253.USD","IE0008369823.USD","SG9999004220.SGD","LU0067412154.USD","LU0326950275.SGD","LU1226288170.HKD","LU1813983027.USD","01093","BK1521","LU1951186391.HKD","LU1152091168.USD","IE00B5MMRT66.SGD","BK1515","LU1226287875.USD","LU0501845795.SGD","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141819089","title":"CSPC Pharma's SYS6052 Shingles Vaccine Enters Phase I/II Clinical Trials in China","url":"https://stock-news.laohu8.com/highlight/detail?id=1141819089","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141819089?lang=en_us&edition=fundamental","pubTime":"2026-11-02 18:50","pubTimestamp":1793616618,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group Limited (01093) has announced that Phase I/II clinical trials for SYS6052, a recombinant herpes zoster virus vaccine (Chinese Hamster Ovary (CHO) cells) developed by the...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0315179316.USD","LU0326950275.SGD","PSYK","IE00B031HY20.USD","LU1152091754.HKD","LU0501845795.SGD","IE00BZ08YS42.EUR","LU0140636845.USD","LU0067412154.USD","HK0000165453.HKD","LU1993786604.SGD","IE0008369823.USD","LU1328277881.USD","01093","LU1226287792.SGD","IBBQ","BK1191","LU1152091168.USD","IBBJ","LU1226287875.USD","LU1813983027.USD","159646","IE00BZ08YR35.GBP","BK1521","LU1951186391.HKD","KURE","IE00BZ08YT58.USD","LU0072913022.USD","LU0314109678.HKD","IE00B5MMRT66.SGD","BK1515","LU2039709279.SGD","LU1960683339.HKD","BMED","LU1226287529.USD","LU1807302812.USD","LU1008478684.HKD","MDTX","SG9999004220.SGD","IE00B543WZ88.USD","LU0880133367.SGD","LU1226288253.USD","LU1226288170.HKD","IE0008368742.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680975589","title":"CSPC Pharmaceutical - Co Obtains Phase Iii Topline Data for Triple Combination in Type 2 Diabetes","url":"https://stock-news.laohu8.com/highlight/detail?id=2680975589","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680975589?lang=en_us&edition=fundamental","pubTime":"2026-11-02 18:49","pubTimestamp":1793616544,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261102:nFWN46J0YU:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1813983027.USD","BK1191","IE00BZ08YT58.USD","LU1226287875.USD","IE00BZ08YS42.EUR","LU0067412154.USD","01093","LU1328277881.USD","LU1993786604.SGD","LU1960683339.HKD","IE0008368742.USD","LU0501845795.SGD","IE00B031HY20.USD","LU0315179316.USD","LU0140636845.USD","LU2039709279.SGD","IE00BZ08YR35.GBP","SG9999004220.SGD","BK1521","LU0314109678.HKD","BK1515","LU1152091168.USD","LU0072913022.USD","KURE","LU1226287792.SGD","IE00B543WZ88.USD","HK0000165453.HKD","LU1807302812.USD","IE00B5MMRT66.SGD","LU1951186391.HKD","LU0880133367.SGD","LU0326950275.SGD","LU1226287529.USD","LU1226288170.HKD","LU1152091754.HKD","LU1226288253.USD","LU1008478684.HKD","IE0008369823.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680896755","title":"CSPC Pharmaceutical - Phase Iii Trial of Prusogliptin, Dapagliflozin, Metformin Achieves Positive Topline Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2680896755","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680896755?lang=en_us&edition=fundamental","pubTime":"2026-11-02 18:49","pubTimestamp":1793616544,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261102:nFWN46J0YU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE0008369823.USD","SG9999004220.SGD","LU1226287875.USD","IE0008368742.USD","LU0140636845.USD","LU1960683339.HKD","BK1515","LU1226287792.SGD","IE00BZ08YS42.EUR","LU0067412154.USD","LU0315179316.USD","LU2039709279.SGD","LU0326950275.SGD","LU1226288253.USD","HK0000165453.HKD","BK1191","LU1993786604.SGD","LU1008478684.HKD","IE00B031HY20.USD","LU1226287529.USD","LU0501845795.SGD","LU1328277881.USD","IE00B543WZ88.USD","LU1152091168.USD","IE00BZ08YT58.USD","LU1813983027.USD","LU0314109678.HKD","LU1951186391.HKD","IE00BZ08YR35.GBP","LU0072913022.USD","LU1807302812.USD","KURE","BK1521","LU1226288170.HKD","LU1152091754.HKD","IE00B5MMRT66.SGD","01093","LU0880133367.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680753701","title":"CSPC Pharmaceutical - Co Initiates Phase I Clinical Trial of Sys6057 Rsv Vaccine in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2680753701","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680753701?lang=en_us&edition=fundamental","pubTime":"2026-11-02 18:44","pubTimestamp":1793616247,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261102:nFWN46J1EN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1152091754.HKD","LU1807302812.USD","01093","IE00BZ08YS42.EUR","LU1008478684.HKD","IE00B543WZ88.USD","LU1960683339.HKD","IE00BZ08YT58.USD","LU0880133367.SGD","LU2039709279.SGD","LU1226287875.USD","LU1328277881.USD","LU1813983027.USD","LU1951186391.HKD","BK1521","BK1515","LU1152091168.USD","KURE","SG9999004220.SGD","LU1226288253.USD","LU0067412154.USD","BK1191","LU0072913022.USD","IE0008368742.USD","LU0140636845.USD","IE00BZ08YR35.GBP","LU0326950275.SGD","HK0000165453.HKD","LU0501845795.SGD","LU0315179316.USD","LU0314109678.HKD","LU1226288170.HKD","LU1993786604.SGD","IE00B031HY20.USD","IE0008369823.USD","LU1226287529.USD","LU1226287792.SGD","IE00B5MMRT66.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679601243","title":"Should Clinical Trial Progress Require Action From CSPC Pharma (SEHK:1093) Investors?","url":"https://stock-news.laohu8.com/highlight/detail?id=2679601243","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679601243?lang=en_us&edition=fundamental","pubTime":"2026-10-30 21:45","pubTimestamp":1793367908,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group reported past Phase I/II data at ESMO 2026 for oncology assets SYS6043 and SYS6090, while also moving SYS6043 into Phase III and advancing mid stage trials for RSV and dry eye candidates in China.\nThe cluster of oncology, RSV and ophthalmology trials points to rising development spend, as well as a broader late stage pipeline that could reshape CSPC Pharmaceutical Group’s future product mix if later outcomes support regulatory progress.\nThe focus now shifts to how...","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6121000-choice2-card/1788952923351","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6121000-choice2-card/1788952923351"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1093/cspc-pharmaceutical-group-shares/news/should-clinical-trial-progress-require-action-from-cspc-phar","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1093/cspc-pharmaceutical-group-shares/news/should-clinical-trial-progress-require-action-from-cspc-phar","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE0008368742.USD","LU1226288253.USD","LU1328277881.USD","LU0326950275.SGD","LU1152091168.USD","LU1008478684.HKD","LU0314109678.HKD","LU1993786604.SGD","IE00B031HY20.USD","LU2065732104.USD","LU1226288170.HKD","BK1515","LU1813983027.USD","KURE","LU0140636845.USD","SG9999004220.SGD","IE00BZ08YR35.GBP","BK1521","IE00B543WZ88.USD","PRGS","LU0880133367.SGD","LU1226287875.USD","IE00B5MMRT66.SGD","LU1960683339.HKD","01093","LU0067412154.USD","BK1191","LU1226287792.SGD","LU0315179316.USD","BK4211","LU0501845795.SGD","LU1807302812.USD","LU1226287529.USD","HK0000165453.HKD","ISBC","LU2039709279.SGD","IE0008369823.USD","LU1152091754.HKD","LU0072913022.USD","IE00BZ08YT58.USD","IE00BZ08YS42.EUR","LU1951186391.HKD","BK4097"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679297976","title":"CSPC Pharmaceutical Starts Phase I/II Trial of Sys6043 for Advanced Solid Tumors in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2679297976","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679297976?lang=en_us&edition=fundamental","pubTime":"2026-10-30 18:40","pubTimestamp":1793356824,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Starts Phase I/II Trial of SYS6043 for Advanced Solid Tumors in ChinaCSPC Pharmaceutical Group announced Oct. 30, 2026, that its Phase I/II SYS6043 trial began at its first Chinese","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261030:nNDL1BSvNh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0067412154.USD","LU0880133367.SGD","LU1226287875.USD","LU1813983027.USD","SG9999004220.SGD","KURE","LU1226288253.USD","IE0008369823.USD","LU0501845795.SGD","LU0326950275.SGD","LU0140636845.USD","LU0314109678.HKD","LU0072913022.USD","LU1328277881.USD","IE0008368742.USD","BK1515","LU1008478684.HKD","LU2039709279.SGD","IE00B543WZ88.USD","IE00BZ08YS42.EUR","LU1951186391.HKD","IE00B5MMRT66.SGD","LU1152091168.USD","01093","LU1226288170.HKD","LU1152091754.HKD","LU1960683339.HKD","BK1521","HK0000165453.HKD","LU1993786604.SGD","BK1191","IE00B031HY20.USD","IE00BZ08YR35.GBP","LU1226287529.USD","LU1807302812.USD","IE00BZ08YT58.USD","LU1226287792.SGD","LU0315179316.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184341664","title":"CSPC Pharma's SYS6043 Phase I/II Trial for Advanced Solid Tumors Launches at First Site in China","url":"https://stock-news.laohu8.com/highlight/detail?id=1184341664","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184341664?lang=en_us&edition=fundamental","pubTime":"2026-10-30 18:40","pubTimestamp":1793356819,"startTime":"0","endTime":"0","summary":"The Phase I/II clinical trial of CSPC PHARMA (01093) investigating SYS6043 (B7-H3-ADC) as a monotherapy or in combination with bevacizumab and/or chemotherapy in participants with advanced solid...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0140636845.USD","LU0067412154.USD","LU0880133367.SGD","IE00B031HY20.USD","IE0008369823.USD","SG9999004220.SGD","LU0315179316.USD","LU1152091754.HKD","LU1813983027.USD","IE00B543WZ88.USD","LU1951186391.HKD","IBBQ","IE00BZ08YT58.USD","LU1807302812.USD","LU1008478684.HKD","LU1328277881.USD","LU1152091168.USD","LU0072913022.USD","LU0501845795.SGD","LU1226287875.USD","IE00B5MMRT66.SGD","IE00BZ08YR35.GBP","LU0314109678.HKD","LU1993786604.SGD","01093","HK0000165453.HKD","LU1226288253.USD","LU1226287529.USD","LU1226287792.SGD","IE00BZ08YS42.EUR","LU1960683339.HKD","LU0326950275.SGD","LU1226288170.HKD","BK1521","IE0008368742.USD","BMED","BK1191","LU2039709279.SGD","BK1515","MDTX","IBBJ","PSYK","KURE"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cspc.com.hk","stockEarnings":[{"period":"1week","weight":0.0489},{"period":"1month","weight":-0.1341},{"period":"3month","weight":0.0038},{"period":"6month","weight":0.0639},{"period":"1year","weight":0.187},{"period":"ytd","weight":0.0349}],"compareEarnings":[{"period":"1week","weight":0.0357},{"period":"1month","weight":-0.005},{"period":"3month","weight":-0.0631},{"period":"6month","weight":-0.0937},{"period":"1year","weight":-0.0783},{"period":"ytd","weight":-0.0668}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"CSPC Pharmaceutical Group Ltd is a company primarily engaged in the production and sales of pharmaceuticals. The Company's main businesses include finished drug manufacturing, bulk product business, functional food and other businesses. The Company's products mainly cover the nervous system, anti-tumor, anti-infective, cardiovascular, respiratory system, digestive and metabolic, and other therapeutic areas. The Company conducts its businesses in domestic and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.53125,"avgChangeRate":0.00944},{"month":2,"riseRate":0.75,"avgChangeRate":0.095107},{"month":3,"riseRate":0.46875,"avgChangeRate":0.017429},{"month":4,"riseRate":0.59375,"avgChangeRate":0.057786},{"month":5,"riseRate":0.59375,"avgChangeRate":0.042699},{"month":6,"riseRate":0.3125,"avgChangeRate":0.001865},{"month":7,"riseRate":0.393939,"avgChangeRate":0.015797},{"month":8,"riseRate":0.454545,"avgChangeRate":0.011796},{"month":9,"riseRate":0.515152,"avgChangeRate":0.003034},{"month":10,"riseRate":0.545455,"avgChangeRate":0.00373},{"month":11,"riseRate":0.484848,"avgChangeRate":0.008233},{"month":12,"riseRate":0.5,"avgChangeRate":-0.013214}],"exchange":"SEHK","name":"CSPC PHARMA","nameEN":"CSPC PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.1","shortVersion":"4.52.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CSPC PHARMA(01093),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest CSPC PHARMA(01093) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"CSPC PHARMA,01093,CSPC PHARMA股票,CSPC PHARMA股票老虎,CSPC PHARMA股票老虎国际,CSPC PHARMA行情,CSPC PHARMA股票行情,CSPC PHARMA股价,CSPC PHARMA股市,CSPC PHARMA股票价格,CSPC PHARMA股票交易,CSPC PHARMA股票购买,CSPC PHARMA股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CSPC PHARMA(01093),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest CSPC PHARMA(01093) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}